Imaging to Support the Increase in Active Surveillance
Beyond doubt, the interest in Active Surveillance for prostate cancer (AS, also called Expectant Management) is on the rise. A number of converging factors are driving the increase: Better early detection and diagnosis of low-risk disease Emerging science on which cell lines are unlikely to progress into lethal disease Broader awareness of the risks of keep reading
